Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 181 of 181 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/30/12
End: 12/31/25
Due: 12/31/26
Phase: N/A
Priority: Normal
Start: 12/01/23
End: 01/01/30
Due: 01/01/31
Camrelizumab Combined With Apatinib and Capecitabine in Patients With Advanced Biliary Tract Cancer.
Phase: N/A
Priority: Normal
Start: 01/01/21
End: 05/30/23
Due: 05/30/24
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 03/15/21
End: 04/30/22
Due: 04/30/23
Phase: N/A
Priority: Normal
Start: 01/01/23
End: 12/31/24
Due: 12/31/25